Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy D Mastro

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Eclinicalmedicine|May 31, 2019
HIV Incidence and Risk Behaviours of People Who Inject Drugs in Bangkok, 1995-2012Michael Martin, Suphak Vanichseni, Udomsak Sangkum, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 12, 2009
Blood and seminal plasma HIV-1 RNA levels among HIV-1-infected injecting drug users participating in the AIDSVAX B/E efficacy trial in Bangkok, ThailandWanitchaya Kittikraisak, Frits van Griensven, Michael Martin, et al.
AIDS Research and Human Retroviruses|October 31, 2003
HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassayDale J Hu, Suphak Vanichseni, Philip A Mock, et al.
Plos One|May 9, 2024
Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trialG Justus Hofmeyr, Mandisa Singata-Madliki, Joanne Batting, et al.
Sexually Transmitted Infections|November 19, 2020
Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implantJennifer Deese, Neena Philip, Margaret Lind, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 19, 2006
Safety and acceptability of the candidate microbicide Carraguard in Thai Women: findings from a Phase II Clinical TrialPeter H Kilmarx, Janneke H H M van de Wijgert, Supaporn Chaikummao, et al.
Journal of the International AIDS Society|May 13, 2020
Integrating oral PrEP delivery among African women in a large HIV endpoint-driven clinical trialIvana Beesham, Julia D Welch, Renee Heffron, et al.
BMC Infectious Diseases|September 28, 2011
HIV surveillance in a large, community-based study: results from the pilot study of Project Accept (HIV Prevention Trials Network 043)Estelle Piwowar-Manning, Agnes Fiamma, Oliver Laeyendecker, et al.
The Lancet. HIV|June 14, 2021
Incorporating oral PrEP into standard prevention services for South African women: a nested interrupted time-series studyDeborah Donnell, Ivana Beesham, Julia D Welch, et al.
AIDS Research and Human Retroviruses|May 13, 2020
Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease ProgressionCharles S Morrison, G Justus Hofmeyr, Katherine K Thomas, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Eclinicalmedicine|May 31, 2019
HIV Incidence and Risk Behaviours of People Who Inject Drugs in Bangkok, 1995-2012Michael Martin, Suphak Vanichseni, Udomsak Sangkum, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 12, 2009
Blood and seminal plasma HIV-1 RNA levels among HIV-1-infected injecting drug users participating in the AIDSVAX B/E efficacy trial in Bangkok, ThailandWanitchaya Kittikraisak, Frits van Griensven, Michael Martin, et al.
AIDS Research and Human Retroviruses|October 31, 2003
HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassayDale J Hu, Suphak Vanichseni, Philip A Mock, et al.
Plos One|May 9, 2024
Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trialG Justus Hofmeyr, Mandisa Singata-Madliki, Joanne Batting, et al.
Sexually Transmitted Infections|November 19, 2020
Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implantJennifer Deese, Neena Philip, Margaret Lind, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 19, 2006
Safety and acceptability of the candidate microbicide Carraguard in Thai Women: findings from a Phase II Clinical TrialPeter H Kilmarx, Janneke H H M van de Wijgert, Supaporn Chaikummao, et al.
Journal of the International AIDS Society|May 13, 2020
Integrating oral PrEP delivery among African women in a large HIV endpoint-driven clinical trialIvana Beesham, Julia D Welch, Renee Heffron, et al.
BMC Infectious Diseases|September 28, 2011
HIV surveillance in a large, community-based study: results from the pilot study of Project Accept (HIV Prevention Trials Network 043)Estelle Piwowar-Manning, Agnes Fiamma, Oliver Laeyendecker, et al.
The Lancet. HIV|June 14, 2021
Incorporating oral PrEP into standard prevention services for South African women: a nested interrupted time-series studyDeborah Donnell, Ivana Beesham, Julia D Welch, et al.
AIDS Research and Human Retroviruses|May 13, 2020
Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease ProgressionCharles S Morrison, G Justus Hofmeyr, Katherine K Thomas, et al.
Pageof 8